In addition to cervical cancer, enhanced Ezrin expression is a new, independent prognostic marker in endometrioid carcinoma and is correlated with endometrioid carcinoma stages (FIGO) (Kobel et al., 2006). This evidence concerns the gene EZR and endometrioid adenocarcinoma.